Hipragumboro BPL 2 Formulation:   Each dose contains:   Each 0.5 mL (dose) contains:   Newcastle Disease (ND) Virus (La Sota Strain)........... >1/16 HAI Titer Infectious Bursal Disease (IBD) Virus (W2512 Strain) .... > 357 ELISA Titer HAI - Hemagglutination Inhibition ELISA - Enzyme-Linked Immunosorbent Assay Emulsion for Injection   (IM/SC) Filipinas - inglés - FDA (Food And Drug Administration)

hipragumboro bpl 2 formulation: each dose contains: each 0.5 ml (dose) contains: newcastle disease (nd) virus (la sota strain)........... >1/16 hai titer infectious bursal disease (ibd) virus (w2512 strain) .... > 357 elisa titer hai - hemagglutination inhibition elisa - enzyme-linked immunosorbent assay emulsion for injection (im/sc)

hipra philippines, inc.; distributor: hipra philippines, inc. - inactivated infectious bursal disease (ibd) virus , newcastle disease (nd) virus vaccine (vet.) - emulsion for injection (im/sc) - formulation: each dose contains: each 0.5 ml (dose) contains: newcastle disease (nd) virus (la sota strain)........... >1/16 hai titer infectious bursal disease (ibd) virus (w2512 strain) .... > 357 elisa titer hai - hemagglutination inhibition elisa - enzyme-linked immunosorbent assay

Bronipra ND/IBD Formulation:  Each 0.5 mL (dose) contains:  Newcastle Disease Virus (La Sota Strain)...... > 1/16 IHA Titer Infectious Bronchitis Virus (H52 Strain) ........ >228 ELISA Titer IHA - Hemagglutination Inhibition ELISA - Enzyme-Linked Immunosorbent Assay  Processed under FDA Memorandum Circular 2021-001. Emulsion for Injection (IM/SC) Filipinas - inglés - FDA (Food And Drug Administration)

bronipra nd/ibd formulation: each 0.5 ml (dose) contains: newcastle disease virus (la sota strain)...... > 1/16 iha titer infectious bronchitis virus (h52 strain) ........ >228 elisa titer iha - hemagglutination inhibition elisa - enzyme-linked immunosorbent assay processed under fda memorandum circular 2021-001. emulsion for injection (im/sc)

hipra philippines, inc.; distributor: hipra philippines, inc. - inactivated newcastle disease (nd) virus , infectious bronchitis (ib) virus, infectious bursal disease virus vaccine (vet.) - emulsion for injection (im/sc) - formulation: each 0.5 ml (dose) contains: newcastle disease virus (la sota strain)...... > 1/16 iha titer infectious bronchitis virus (h52 strain) ........ >228 elisa titer iha - hemagglutination inhibition elisa - enzyme-linked immunosorbent assay processed under fda memorandum circular 2021-001.

Nobilis REO Inac Formulation:   Each 0.5 mL (dose) contains:   Reovirus (1733 and 2408 Strain).... >7.4 log2 ELISA units ELISA - Enzyme-Linked Immunosorbent Assay Emulsion for Injection   (IM/SC) Filipinas - inglés - FDA (Food And Drug Administration)

nobilis reo inac formulation: each 0.5 ml (dose) contains: reovirus (1733 and 2408 strain).... >7.4 log2 elisa units elisa - enzyme-linked immunosorbent assay emulsion for injection (im/sc)

msd animal health (phils.), inc. - inactivated reovirus vaccine (vet.) - emulsion for injection (im/sc) - formulation: each 0.5 ml (dose) contains: reovirus (1733 and 2408 strain).... >7.4 log2 elisa units elisa - enzyme-linked immunosorbent assay

Eryseng Parvo Each 2 mL (dose) contains:   Porcine Parvovirus (NADL-2 Strain) ................. 2 1.15 RP Erysiphelothrix rhusiopathiae (R32E11 Strain) ..... > 3.34 IE50 RP - Relative Potency IE - Inhibition ELISA (Enzyme-Linked Immunosorbent Assay) Suspension for Injection   (IM) Filipinas - inglés - FDA (Food And Drug Administration)

eryseng parvo each 2 ml (dose) contains: porcine parvovirus (nadl-2 strain) ................. 2 1.15 rp erysiphelothrix rhusiopathiae (r32e11 strain) ..... > 3.34 ie50 rp - relative potency ie - inhibition elisa (enzyme-linked immunosorbent assay) suspension for injection (im)

hipra philippines, inc.; distributor: hipra philippines, inc. - inactivated porcine parvovirus (ppv) , erysiphelothrix rhusiopathiae vaccine (vet.) - suspension for injection (im) - each 2 ml (dose) contains: porcine parvovirus (nadl-2 strain) ................. 2 1.15 rp erysiphelothrix rhusiopathiae (r32e11 strain) ..... > 3.34 ie50 rp - relative potency ie - inhibition elisa (enzyme-linked immunosorbent assay)

Rhiniffa T Formulation:   Each 2 mL (dose) contains:   Bordetella bronchiseptica (372CN Strain) ...... ......... >0.9 SA Unit Pasteurella multocida (M17 Strain) ...................... >0.9 ELISA Unit Pasteurella multocida (M17 Strain) Toxoid.............. >1 ELISA Unit SA - Seroagglutinating Unit to obtain 1 log 10 seroagglutinating antibodies in laboratory animals ELISA - Enzyme-Linked Immunosorbent Assay Unit to obtain 1 log10 seroagglutinating antibodies in laboratory animals Suspension for Injection (IM) Filipinas - inglés - FDA (Food And Drug Administration)

rhiniffa t formulation: each 2 ml (dose) contains: bordetella bronchiseptica (372cn strain) ...... ......... >0.9 sa unit pasteurella multocida (m17 strain) ...................... >0.9 elisa unit pasteurella multocida (m17 strain) toxoid.............. >1 elisa unit sa - seroagglutinating unit to obtain 1 log 10 seroagglutinating antibodies in laboratory animals elisa - enzyme-linked immunosorbent assay unit to obtain 1 log10 seroagglutinating antibodies in laboratory animals suspension for injection (im)

boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - inactivated bordetella bronchiseptica , pasteurella multocida vaccine (vet.) : - suspension for injection (im) - formulation: each 2 ml (dose) contains: bordetella bronchiseptica (372cn strain) ...... ......... >0.9 sa unit pasteurella multocida (m17 strain) ...................... >0.9 elisa unit pasteurella multocida (m17 strain) toxoid.............. >1 elisa unit sa - seroagglutinating unit to obtain 1 log 10 seroagglutinating antibodies in laboratory animals elisa - enzyme-linked immunosorbent assay unit to obtain 1 log10 seroagglutinating antibodies in laboratory animals

Hyobloc® Formulation: Each 2 mL (dose) contains: Mycoplasma hyopneumoniae (2940 Strain).............................>2.75 ELISA Units Enzyme-Linked Immunosorbent Assay (ELISA) Emulsion for Injection (IM) Filipinas - inglés - FDA (Food And Drug Administration)

hyobloc® formulation: each 2 ml (dose) contains: mycoplasma hyopneumoniae (2940 strain).............................>2.75 elisa units enzyme-linked immunosorbent assay (elisa) emulsion for injection (im)

ceva animal health (philippines), inc.; distributor: ceva animal health (philippines), inc. - inactivated mycoplasma hyopneumoniae vaccine (vet.) - emulsion for injection (im) - formulation: each 2 ml (dose) contains: mycoplasma hyopneumoniae (2940 strain).............................>2.75 elisa units enzyme-linked immunosorbent assay (elisa)

Hyogen Formulation: Each 2 mL (dose) contains: Mesomycoplasma hyopneumoniae (Strain 2940)..   > 2.75 ELISA Units Enzyme-Linked Immunosorbent Assay (ELISA) Emulsion for Injection (IM) Filipinas - inglés - FDA (Food And Drug Administration)

hyogen formulation: each 2 ml (dose) contains: mesomycoplasma hyopneumoniae (strain 2940).. > 2.75 elisa units enzyme-linked immunosorbent assay (elisa) emulsion for injection (im)

ceva animal health (philippines), inc.; distributor: ceva animal health (philippines), inc. - inactivated mesomycoplasma hyopneumoniae vaccine (vet.) - emulsion for injection (im) - formulation: each 2 ml (dose) contains: mesomycoplasma hyopneumoniae (strain 2940).. > 2.75 elisa units enzyme-linked immunosorbent assay (elisa)

Circovac Formulation: Each 2 mL (dose) contains: Porcine Circovirus Type 2 (PCV2).   > 2.1 log^10 ELISA Units Enzyme-Linked Immunosorbent Assay (ELISA) Suspension for Injection   (IM) Filipinas - inglés - FDA (Food And Drug Administration)

circovac formulation: each 2 ml (dose) contains: porcine circovirus type 2 (pcv2). > 2.1 log^10 elisa units enzyme-linked immunosorbent assay (elisa) suspension for injection (im)

ceva animal health (philippines), inc.; distributor: ceva animal health (philippines), inc. - inactivated porcine circovirus (pcv) vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: porcine circovirus type 2 (pcv2). > 2.1 log^10 elisa units enzyme-linked immunosorbent assay (elisa)

Circovac Each 2 mL (dose) contains: Porcine Circovirus (PCV) (Type 2).   2 2.1 log" ELISA ELISA - Enzyme-Linked Immunosorbent Assay Units Suspension for Injection   (IM) Filipinas - inglés - FDA (Food And Drug Administration)

circovac each 2 ml (dose) contains: porcine circovirus (pcv) (type 2). 2 2.1 log" elisa elisa - enzyme-linked immunosorbent assay units suspension for injection (im)

ceva animal health (philippines), inc.; distributor: ceva animal health (philippines), inc. - inactivated porcine circovirus (pcv) vaccine (vet.) - suspension for injection (im) - each 2 ml (dose) contains: porcine circovirus (pcv) (type 2). 2 2.1 log" elisa elisa - enzyme-linked immunosorbent assay units

Izovac ND-IBD Formulation:   Each 0.5 mL (dose) contains:   Newcastle Disease Virus (Ulster Strain) ..   Infectious Bursal Disease Virus (Winterfield 2512 Strain)   * Hemagglutination Inhibition (HI) units after injection of chickens with 1/50 dose ** Enzyme-Linked Immunosorbent Assay (ELISA) S/P ratio   ≥ 4.0 log2 HI Units* S/P ≥0.25** Emulsion for Injection (IM) Filipinas - inglés - FDA (Food And Drug Administration)

izovac nd-ibd formulation: each 0.5 ml (dose) contains: newcastle disease virus (ulster strain) .. infectious bursal disease virus (winterfield 2512 strain) * hemagglutination inhibition (hi) units after injection of chickens with 1/50 dose ** enzyme-linked immunosorbent assay (elisa) s/p ratio ≥ 4.0 log2 hi units* s/p ≥0.25** emulsion for injection (im)

farmline agriventures, inc.; distributor: farmline agriventures, inc. - inactivated newcastle disease (nd) virus, infectious bursal disease (ibd) virus vaccine (vet.) - emulsion for injection (im) - formulation: each 0.5 ml (dose) contains: newcastle disease virus (ulster strain) .. infectious bursal disease virus (winterfield 2512 strain) * hemagglutination inhibition (hi) units after injection of chickens with 1/50 dose ** enzyme-linked immunosorbent assay (elisa) s/p ratio ≥ 4.0 log2 hi units* s/p ≥0.25**